Xu et al. revealed that silencing PBX3 resulted in a significant increase in the percentage of cells in G0/G1 phases by decreasing the expression of CDKs and increasing the expression of CDKis, thereby inhibiting cell proliferation and inducing apoptosis in glioma.14 Here, PBX3 is linked to central nervous system cancer.